These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10994734)

  • 1. The role of fatty acids in cardiac imaging.
    Tamaki N; Morita K; Kuge Y; Tsukamoto E
    J Nucl Med; 2000 Sep; 41(9):1525-34. PubMed ID: 10994734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic imaging using SPECT.
    Taki J; Matsunari I
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S34-48. PubMed ID: 17479263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Different patterns of 123I-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency].
    Watanabe K; Toba K; Ogawa Y; Aizawa Y; Tanabe N; Miyajima S; Kusano Y; Nagatomo T; Hirokawa Y
    Kaku Igaku; 1997 Dec; 34(12):1125-30. PubMed ID: 9494334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of washout rate between planar image and polar map image: 123I-BMIPP study.
    Otsuka H; Hieda M; Shinbata H; Kubo A; Nishitani H
    J Med Invest; 2003 Aug; 50(3-4):176-9. PubMed ID: 13678387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Study of a Radiopharmaceutical Agent Based on Modified Fatty Acid Labeled with Technetium-99m.
    Sazonova SI; Il'yushenkova YN; Lishmanov YB; Tsibul'nikov SV; Skuridin VS; Nesterov EA; Varlamova NV; Il'ina EA; Filimonov VD; Belyanin MV; Stepanova EV; Minin SM
    Bull Exp Biol Med; 2017 Apr; 162(6):746-749. PubMed ID: 28429212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial imaging and metabolic studies with [17-123I]iodoheptadecanoic acid.
    Freundlieb C; Höck A; Vyska K; Feinendegen LE; Machulla HJ; Stöcklin G
    J Nucl Med; 1980 Nov; 21(11):1043-50. PubMed ID: 7431103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fatty acid metabolism in hearts after ischemia-reperfusion injury using a dual-isotope autoradiographic approach and tissue assay for metabolites of tracer.
    Igarashi N; Nozawa T; Fujii N; Kato B; Nonomura M; Matsuki A; Nakadate T; Igawa A; Asanoi H; Inoue M; Inoue H
    J Nucl Med; 2005 Jan; 46(1):160-4. PubMed ID: 15632047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Japanese experience with metabolic imaging in the clinical setting.
    Tamaki N; Morita K; Kawai Y
    J Nucl Cardiol; 2007; 14(3 Suppl):S145-52. PubMed ID: 17556183
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of metabolic substrate on BMIPP metabolism in canine myocardium.
    Nohara R; Hosokawa R; Hirai T; Okuda K; Ogino M; Fujibayashi Y; Fujita M; Sasayama S
    J Nucl Med; 1998 Jul; 39(7):1132-7. PubMed ID: 9669382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic imaging using PET.
    Kudo T
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S49-61. PubMed ID: 17486339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
    Mori H; Sakamoto T; Ueda Y; Yano K
    J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac receptor physiology and imaging: an update.
    Chen GP; Tabibiazar R; Branch KR; Link JM; Caldwell JH
    J Nucl Cardiol; 2005; 12(6):714-30. PubMed ID: 16344234
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical value of BMIPP on the evaluation of myocardial ischemia and metabolism before and after CABG].
    Hayashi I; Makuuchi H; Naruse Y; Kobayashi T; Yamamoto T; Hariya A; Maruno H; Murata H
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Jul; 44(7):912-7. PubMed ID: 8741549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolism in the heart--contribution of BMIPP to the diseased heart.
    Nohara R
    Ann Nucl Med; 2001 Oct; 15(5):403-9. PubMed ID: 11758944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial metabolism of radioiodinated BMIPP.
    Knapp FF
    J Nucl Med; 1995 Jun; 36(6):1051-4. PubMed ID: 7769427
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency).
    Fukuchi K; Nozaki S; Yoshizumi T; Hasegawa S; Uehara T; Nakagawa T; Kobayashi T; Tomiyama Y; Yamashita S; Matsuzawa Y; Nishimura T
    J Nucl Med; 1999 Feb; 40(2):239-43. PubMed ID: 10025829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging myocardial metabolism.
    Yoshinaga K; Tamaki N
    Curr Opin Biotechnol; 2007 Feb; 18(1):52-9. PubMed ID: 17157495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide imaging of myocardial metabolism.
    Peterson LR; Gropler RJ
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):211-22. PubMed ID: 20233863
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of radioiodinated fatty acid myocardial imaging agents in animal models and human studies.
    Knapp FF; Kropp J; Franken PR; Visser FC; Sloof GW; Eisenhut M; Yamamichi Y; Shirakami Y; Kusuoka H; Nishimura T
    Q J Nucl Med; 1996 Sep; 40(3):252-69. PubMed ID: 8961803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized non-invasive assessment of myocardial free fatty acid kinetics by means of 15-(para-iodo-phenyl) pentadecanoic acid (123I-pPPA)scintigraphy: I. Method.
    Wieler H; Kaiser KP; Frank J; Kuikka JT; Ladwein K; Winkens A
    Nucl Med Commun; 1990 Dec; 11(12):865-78. PubMed ID: 2284084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.